|
[1]NATARAJAN SK,THANGARAJ KR,EAPEN CE,et al.Liver injury in acute fatty liver of pregnancy:possible link to placental mitochondrial dysfunction and oxidative stress[J].Hepatology,2010,51(1):191-200.
|
|
[2]REYES H,SANDOVAL L,WAINSTEIN A,et al.Acute fatty liver of pregnancy:a clinical study of 12 episodes in 11 patients[J].Gut,1994,35(1):101-106.
|
|
[3]OELY NA,den BOER ME,WIJBURG FA,et al.Long-chain fatty acid oxi-dation during early human development[J].Pediatr Res,2005,57(6):755-759.
|
|
[4]GUTIERREZ JUNQUERA C,BALMASEDA E,GIL E,et al.Acute fatty liver of pregnancy and neonatal long-chain 3-hydroxyacyl-coenzyme Adehydrogenase(LCHAD)deficiency[J].Eur J Pediatr,2009,168(1):103-106.
|
|
[5]RAJASRI AC,SRESTHA R,MITCHELL J.Acute fatty liver of pregnancy(AFLP)-an overview[J].J Obstet Cynaeco,2007,27(3):237-240.
|
|
[6]WESTBROOK RH,YEOMAN AD,JOSHI D,et al.Outcomes of sever pregnancy-related liver disease:refining the role of transplantation[J].Am J Transplant,2010,10(11):2520-2526.
|
|
[7]ZOLLNER G,MARSCHALL HU,WAGNER M,et al.Role of nuclear receptors in the adaptive response to bile acids and cholestasis,pathogenetic and therapeutic considerations[J].Mol Pharm,2006,3(3):2311.
|
|
[8]YAMAMOTO Y,MOORE R,HESS HA,et al.Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity[J].J Biol Chem,2006,281(24):16625-16631.
|
|
[9]MARZI M,VIGANO A,TRABATTONI D,et al.Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy[J].Clin Exp Immunol,1996,106(1):127-133.
|
|
[10]ABU-HAYYEH S,PAPACLEOVOULOU G,LVGREN-SANDBLOM A,et al.Intrahepatic cholestasis of pregnancy levels of sulfated progesterone metabolites inhibit farnesoid X receptor resulting in a cholestatic phenotype[J].Hepatology,2013,57(2):716-726.
|
|
[11]ZHANG J,XU M,WANG XZ,et al.Hepatic disease with pregnancy[J].J Clin Hepatol,2008,24(5):397-399.(in Chinese)张健,徐敏,王心竹,等.妊娠期肝病[J].临床肝胆病杂志,2008,24(5):397-399.
|
|
[12]ABILDGAARD U,HEIMDAL K.Pathogenesis of the syndrome of hemolysis,elevated liver enzymes,and low platelet count(HELLP):a review[J].Eur J Obstet Gynecol Reprod Biol,2013,166(2):117-123.
|
|
[13]MINAKAMI H,MORIKAWA M,YAMADA T,et al.Differentiation of acute fatty liver of pregnancy from syndrome of hemolysis,elevated liver enzymes and low platelet counts[J].J Obstet Gynaecol Res,2014,40(3):641-649.
|
|
[14]DULEY L,MEHER S,JONES L.Drugs for treatment of very high blood pressure during pregnancy[J].Cochrane Database Syst Rev,2013,31(7):1449.
|
|
[15]HARAM K,SVENDSEN E,ABILDGAARD U.The HELLP syndrome:clinical issues and management.A Review[J].BMC Pregnancy Childbirth,2009,9:8.
|
|
[16]WALLACE K,MARTIN JN JR,TAM TAM K,et al.Seeking the mechanism(s)of action for corticosteroids in HELLP syndrome:SMASH study[J].Am J Obstet Gynecol,2013,208(5):e1-e8.
|
|
[17]FITZPATRICK KE,HINSHAW K,KURINCZUK JJ,et al.Risk factors,management,and outcomes of hemolysis,elevated liver enzymes,and low platelets syndrome and elevated liver enzymes,low platelets syndrome[J].Obstet Gynecol,2014,123(3):618-627.
|
|
[18]ERKURT MA,KUKU I,KAYA E,et al.Therapeutic plasma-exchange in hematologic disease:results from a single center in Eastern Anatolia[J].Transfus Apher Sci,2013,48(3):335-339.
|
|
[19]JIANG PR,QIU SX.Analysis of 2137 cases of liver diseases in pregnant women[J].Chin Hepatol,2006,11(4):247-248.(in Chinese)蒋佩茹,邱申熊.妊娠期肝病2137例临床分析[J].肝脏,2006,11(4):247-248.
|
|
[20]SUN KX,LI J,ZHUANG H.Antiviral prevention of hepatitis B transmission from mother-to-infant:current status and challenges[J].Chin J Virai Dis,2012,2(2):81-86.(in Chinese)孙奎霞,李杰,庄辉.抗病毒治疗阻断乙型肝炎病毒母婴传播现状与挑战[J].中国病毒病杂志,2012,2(2):81-86.
|
|
[21]CHEN J,SUN XF,DENG ZR,et al.Efficacy and safety of telbivudine in preventing intrauterine transmission of hepatitis B virus in the third trimester of pregnancy:a systematic review[J].J Pract Hepatol,2014,17(3):249-256.(in Chinese)陈君,孙晓风,邓泽润,等.妊娠晚期应用替比夫定阻断乙型肝炎病毒宫内感染疗效和安全性的系统评价[J].实用肝脏病杂志,2014,17(3):249-256.
|
|
[22]LI XM,SHI MF,YANG YB,et al.Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection[J].World J Gastroenterol,2004,10(21):3215-3217.
|
|
[23]ZHANG L,GUI XE,TETER C,et al.Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine[J].Vaccine,2014,32(46):6091-6097.
|
|
[24]ZHANG L,GUI XE,WANG B,et al.A multi-center study on the efficacy of immunoprophylaxis for mother-to-infant transmission of hepatitis B virus in multi-centers[J].Chin J Pract Gynecol Obstetr,2015,31(1):65-68.(in Chinese)张磊,桂希恩,汪波,等.免疫阻断乙型肝炎病毒母婴传播多中心研究[J].中国实用妇科与产科杂志,2015,31(1):65-68.
|
|
[25]HAN L,ZHANG HW,XIE JX,et al.A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus[J].World J Gastroenterol,2011,17(38):4321-4333.
|
|
[26]SHI Z,YANG Y,MA L,et al.Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus:a systematic review and meta-analysis[J].Obstet Gynecol,2010,116(1):147-159.
|
|
[27]KANG W,DING Z,SHEN L,et al.Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province,China[J].Vaccine,2014,32(27):3362-3366.
|
|
[28]LU LL,CHEN BX,WANG J,et al.Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women[J].Int J Infect Dis,2014,28:41-44.
|
|
[29]JIANG XX,JIN J.Advances in the antiviral therapies for chronic hepatitis B virus among pregnant women[J].Acta Acad Med Sin,2015,37(1):125-128.(in Chinese)蒋小仙,金洁.慢性乙型肝炎病毒感染妇女妊娠期抗病毒治疗进展[J].中国医学科学院学报,2015,37(1):125-128.
|
|
[30]CHEN CY,TU XL,CHENG QH,et al.Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy[J].Chin J Hepatol,2015,23(1):9-12.(in Chinese)陈川英,涂相林,程全红,等.慢性乙型肝炎患者妊娠早期替比夫定抗病毒的疗效及母婴阻断的临床观察[J].中华肝脏病杂志,2015,23(1):9-12.
|
|
[31]HAN GR,CAO MK,ZHAO W,et al.A prospective and openlabel study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection[J].J Hepatol,2011,55(6):1215-1221.
|
|
[32]HAN GR,JIANG HX,WANG GJ,et al.Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus[J].Chin J Hepatol,2012,20(3):201-205.(in Chinese)韩国荣,江红秀,王根菊,等.替比夫定对乙型肝炎病毒高载量孕妇母婴传播的阻断效果及其安全性[J].中华肝脏病杂志,2012,20(3):201-205.
|
|
[33]XU HX,WANG LJ,YU YX,et al.Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus:a meta-analysis[J].Chine J Hepatol,2012,20(10):755-760.(in Chinese)徐鹤翔,王莉娟,余亚新,等.替比夫定阻断乙型肝炎病毒母婴传播效果及安全性的荟萃分析[J].中华肝脏病杂志,2012,20(10):755-760.
|
|
[34] Chinese Society of Obstetrics and Gynecology branch of study group.Chinese Medical Association.Clinical guidelines for the prevention of mother-to-child transmission of hepatitis B virus[J].Chin J Obstetr Gynecol,2013,48(2):151-154.(in Chinese)中华医学会妇产科学分会产科学组.乙型肝炎病毒母婴传播预防临床指南[J].中华妇产科杂志,2013,48(2):151-154.
|
|
[35]HU Y,CHEN J,WEN J,et al.Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus[J].BMC Pregnancy Childbirth,2013,13:119.
|
|
[36] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
|
DownLoad: